Feiqiu Wen
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 13
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Cancer Research top 10%
- Genetics top 10%
-
- Acute Lymphoblastic Leukemia research 14
-
- Nanoparticle-Based Drug Delivery 8
-
- Nanoplatforms for cancer theranostics 7
-
- Neonatal Health and Biochemistry 6
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Epigenetics and DNA Methylation 6
- Co-authors
- Xiaowen ChenSixi LiuSandip PatilHuirong MaiLeonard A. ValentinoAdnan Abdul JabbarYixin ChenTamara Kazarian
- Journals
- SHILAP Revista de lepidopterología (2 papers)Blood (5 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Feiqiu Wen
113 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 128
- Hematology 174
- Cancer Research 219
- Applied Microbiology and Biotechnology 28
- Genetics 124
Countries citing papers authored by Feiqiu Wen
This map shows the geographic impact of Feiqiu Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiqiu Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiqiu Wen more than expected).
Fields of papers citing papers by Feiqiu Wen
This network shows the impact of papers produced by Feiqiu Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiqiu Wen. The network helps show where Feiqiu Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feiqiu Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 29 | |
| 10 | Genetic Characterization of Colistin-Resistant Salmonella enterica ST34 Co-Harbouring Plasmid-Borne mcr-1, blaCTX-M-15 and blaKPC-2 Recovered from a Paediatric Patient in Shenzhen, China | 2022 | 8 |
| 11 | 2021 | 20 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 8 | |
| 18 | 2020 | 203 | |
| 19 | 2019 | 24 | |
| 20 | 2012 | 14 |
About Feiqiu Wen
Feiqiu Wen is a scholar working on Molecular Medicine, Hematology and Genetics, having authored 117 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (14 papers), Antibiotic Resistance in Bacteria (13 papers), Acute Myeloid Leukemia Research (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers), Neonatal Health and Biochemistry (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Molecular Medicine (128 citations), Hematology (174 citations) and Cancer Research (219 citations). Feiqiu Wen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaowen Chen, Sixi Liu, Sandip Patil, Huirong Mai, Leonard A. Valentino, Adnan Abdul Jabbar, Yixin Chen, Tamara Kazarian, Desheng Xiao and Yating Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.